Federal Circuit Grants Panel Rehearing In Label Carve-Out Row

Mealey's (February 11, 2021, 1:32 PM EST) -- WASHINGTON, D.C. — In a two-page order issued Feb. 10, the Federal Circuit U.S. Court of Appeals announced that it will revisit its October 2020 finding that Teva Pharmaceuticals USA Inc....
To view the full article, register now.